Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Recent publications published by researchers at the MRC WIMM.

Exploring the effects of a combined exercise programme on pain and fatigue outcomes in people with systemic sclerosis: study protocol for a large European multi-centre randomised controlled trial

Mitropoulos A. et al, (2022), Trials, 23

Flare during tapering of biological DMARDs in patients with rheumatoid arthritis in routine care: characteristics and predictors

Terslev L. et al, (2022), RMD open, 8

Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquine

Almeida-Brasil CC. et al, (2022), Lupus Science and Medicine, 9

A cluster of type II interferon-regulated genes associates with disease activity in patients with systemic lupus erythematosus

Siddiqi KZ. et al, (2022), Journal of Autoimmunity, 132

Left ventricular size and function in patients with systemic lupus erythematosus associate with lupus anticoagulant: An echocardiographic follow-up study

Myhr KA. et al, (2022), Journal of Autoimmunity, 132

Vagus nerve stimulation as a novel treatment for systemic lupus erythematous: study protocol for a randomised, parallel-group, sham-controlled investigator-initiated clinical trial, the SLE-VNS study

Zinglersen AH. et al, (2022), BMJ open, 12

COLAR: open-label clinical study of IL-6 blockade with tocilizumab for the treatment of immune checkpoint inhibitor-induced colitis and arthritis

Holmstroem RB. et al, (2022), Journal for immunotherapy of cancer, 10

Peptidylarginine Deiminase 2 Gene Polymorphisms in Subjects with Periodontitis Predispose to Rheumatoid Arthritis

Massarenti L. et al, (2022), International Journal of Molecular Sciences, 23

The extent of residual WT HSPCs is associated with the degree of anemia in patients with SF3B1-mutated MDS-RS.

Hofman IJF. et al, (2022), Blood Adv, 6, 4705 - 4709

Longitudinal analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort.

Choi MY. et al, (2022), Annals of the rheumatic diseases, 81, 1143 - 1150

Targeting stem cells in myelodysplastic syndromes and acute myeloid leukemia.

Woll PS. et al, (2022), J Intern Med, 292, 262 - 277

EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome.

Drosos GC. et al, (2022), Annals of the rheumatic diseases, 81, 768 - 779

Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus: the PISCOS study

Piga M. et al, (2022), The Lancet Rheumatology, 4, e441 - e449

The role of environmental exposures and gene-environment interactions in the etiology of systemic lupus erythematous.

Woo JMP. et al, (2022), Journal of internal medicine, 291, 755 - 778

The added value of a European Reference Network on rare and complex connective tissue and musculoskeletal diseases: insights after the first 5 years of the ERN ReCONNET.

Talarico R. et al, (2022), Clinical and experimental rheumatology, 40 Suppl 134, 3 - 11

Comparison of immune checkpoint inhibitor-induced arthritis and reactive arthritis to inform therapeutic strategy.

Jensen AK. et al, (2022), Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 148

T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes.

Ali M. et al, (2022), Nat Biotechnol, 40, 488 - 498

Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.

Almeida-Brasil CC. et al, (2022), Annals of the rheumatic diseases, 81, 370 - 378

Established risk loci for systemic lupus erythematosus at NCF2, STAT4, TNPO3, IRF5 and ITGAM associate with distinct clinical manifestations: A Danish genome-wide association study.

Leffers HCB. et al, (2022), Joint bone spine, 89

DNMT1 Deficiency Impacts on Plasmacytoid Dendritic Cells in Homeostasis and Autoimmune Disease.

Czeh M. et al, (2022), J Immunol, 208, 358 - 370

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?